Chemical and Pharmaceutical Bulletin
Online ISSN : 1347-5223
Print ISSN : 0009-2363
ISSN-L : 0009-2363
65 巻, 4 号
選択された号の論文の16件中1~16を表示しています
Current Topics - Cutting-Edge Science of Cyclodextrin
Current Topics : Reviews
Communications to the Editor
  • Heejoo Park, Yeongji Yu, Hyejin Kim, Eun Lee, Hani Lee, Raok Jeon, Woo ...
    2017 年 65 巻 4 号 p. 349-355
    発行日: 2017/04/01
    公開日: 2017/04/01
    [早期公開] 公開日: 2017/01/27
    ジャーナル フリー HTML
    電子付録

    Many aminodihydroquinoline compounds have been studied to determine their cytotoxicity to cancer cells. However, anti-cancer stem cells (CSCs) activity of aminodihydroquinoline has not been tested in spite that CSC is believed to do an important roles in chemotherapy resistance and recurrence. The CSC selective targeting activities of 10 recently synthesized 2-aminodihydroquinoline analogs were examined on CSCs and bulk culture of a glioblastoma cell line. A diethylaminopropyl substituted aminodihydroquinoline, 5h, showed a strong anti-CSC effect and general cytotoxicity. However, a benzyl substituted aminodihydroquinoline, 5i, displayed the most effective anti-CSC effect, with no or small significant cytotoxic effect in bulk culture conditions. While 5h temporarily enhanced CSC marker-positive cells and eventually suppressed the CSC population, which is similar to other cytotoxic anticancer reagents reported, 5i selectively eliminated CSC marker-positive cells based on fluorescence activated cell sorter (FACS) analysis. 5h also temporarily activated some genes associated with signaling required for CSC, while 5i selectively suppressed these genes supporting that the differential effects are resulted from different molecular responses. In addition, the selective CSC effect is also found against a colon cancer cell line. Collectively, we suggest that these two novel aminodihydroquinoline compounds possess novel anti-CSC effects in colon and brain tumor derived cell lines probably through independent pathways.

    Graphical Abstract Fullsize Image
  • Takashi Okitsu, Take Matsuyama, Takahiro Yamashita, Toru Ishizuka, Hir ...
    2017 年 65 巻 4 号 p. 356-358
    発行日: 2017/04/01
    公開日: 2017/04/01
    ジャーナル フリー HTML
    電子付録

    Red-shifted channelrhodopsins (ChRs) are attractive for optogenetic tools. We developed a new type of red-shifted ChRs that utilized noncovalent incorporation of retinal and 3,4-dehydroretinal-based enamine-type Schiff bases and mutated channelopsin, C1C2-K296G. These ChRs exhibited absorption maxima that were shifted 10–30 nm toward longer wavelengths than that of C1C2-ChR regenerated with all-trans-retinal.

    Graphical Abstract Fullsize Image
    Editor's pick

    In this communication, development of a new type of red-shifted channelrhodopsins (ChRs) is described. Optogenetics is a powerful new technique which allows control of neuronal activity by light, and ChRs are now widely used in optogenetics due to their function of a light-gated cation channel. In neuroscience, ChRs responding to a long-wavelength light are eagerly required, because ChRs now used are maximally sensitive to green and blue light, and does not penetrate tissues. Here developed new type of ChRs model consisted of red-shifted chromophores (retinal-based enamine-type Schiff bases) and mutated channelopsin (C1C2-K296G), in which chromophores were incorporated noncovalently. Thus prepared new ChRs exhibited absorption maxima that were 10-30 nm red-shifted compared with the original C1C2.



Regular Articles
Note
feedback
Top